Literature DB >> 10900935

Prevalence of dementia and impact on intellectual disability services.

M P Janicki1, A J Dalton.   

Abstract

In a statewide survey, dementia was found in 3% of adults age 40+; 6%, age 60+; and 12%, age 80+. Among adults with Down syndrome, the rates were 22% for adults age 40+ and 56% for adults age 60+. Observed onset occurred in the mid-60s (early 50s for those with Down syndrome). Alzheimer-type dementia was the most frequent diagnosis. With the occurrence of dementia expected to rise proportionately with the increase of longevity among adults with intellectual disabilities, care systems will have to raise the "index of suspicion" among staff and families, become "dementia capable," and improve their diagnostic and technical resources, as well as their care management supports designed to prolong the "aging in place" of adults affected by dementia.

Entities:  

Mesh:

Year:  2000        PMID: 10900935     DOI: 10.1352/0047-6765(2000)038<0276:PODAIO>2.0.CO;2

Source DB:  PubMed          Journal:  Ment Retard        ISSN: 0047-6765


  27 in total

1.  Vitamin E in aging persons with Down syndrome: A randomized, placebo-controlled clinical trial.

Authors:  Mary Sano; Paul S Aisen; Howard F Andrews; Wei-Yann Tsai; Florence Lai; Arthur J Dalton
Journal:  Neurology       Date:  2016-05-04       Impact factor: 9.910

2.  Unraveling the mystery of cognitive reserve.

Authors:  Anjali Bhat
Journal:  J Biosci       Date:  2015-06       Impact factor: 1.826

Review 3.  Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.

Authors:  Yili Wu; Philip T T Ly; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

Review 4.  Improving Memory and Cognition in Individuals with Down Syndrome.

Authors:  Michael S Rafii
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

5.  Cause of death in adults with Down syndrome in the United States.

Authors:  Scott D Landes; J Dalton Stevens; Margaret A Turk
Journal:  Disabil Health J       Date:  2020-06-10       Impact factor: 2.554

Review 6.  On the promise of pharmacotherapies targeted at cognitive and neurodegenerative components of Down syndrome.

Authors:  Alberto C S Costa
Journal:  Dev Neurosci       Date:  2011-09-02       Impact factor: 2.984

7.  Stability and change in health, functional abilities, and behavior problems among adults with and without Down syndrome.

Authors:  Anna J Esbensen; Marsha Mailick Seltzer; Marty Wyngaarden Krauss
Journal:  Am J Ment Retard       Date:  2008-07

8.  Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B.

Authors:  Benjamin L Handen; Ann D Cohen; Umapathy Channamalappa; Peter Bulova; Sheila A Cannon; William I Cohen; Chester A Mathis; Julie C Price; William E Klunk
Journal:  Alzheimers Dement       Date:  2012-11       Impact factor: 21.566

9.  Alzheimer's Disease in Down Syndrome.

Authors:  Elizabeth Head; David Powell; Brian T Gold; Frederick A Schmitt
Journal:  Eur J Neurodegener Dis       Date:  2012-12

10.  Intellectual Disability, Mild Cognitive Impairment, and Risk for Dementia.

Authors:  Wayne P Silverman; Warren B Zigman; Sharon J Krinsky-McHale; Robert Ryan; Nicole Schupf
Journal:  J Policy Pract Intellect Disabil       Date:  2013-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.